EXPRESS: Beyond structural fragility in germinal matrix hemorrhage: a protease-threshold model of developmental...

Germinal matrix hemorrhage (GMH) is a localized form of developmental cerebral microvascular failure and a major cause of mortality and long-term neurological disability in preterm infants. The GM is a highly angiogenic, protease-active developmental niche that operates near the limits of vascular stability under tightly regulated intrauterine conditions. Preterm birth disrupts this balance by removing late-gestational immune modulation and exposing protease-primed GM vessels to exaggerated inflammatory activation. Dysregulated innate immune responses amplify endothelial junctional cleavage and basement-membrane degradation and reprogram the local myeloid environment toward neutrophil-derived protease release. We propose a unified protease-threshold framework in which GMH occurs when inflammatory amplification drives proteolytic activity beyond the structural resilience of the immature GM vasculature. This model may help account for the timing, localization, and heterogeneity of GMH and provides a testable framework for studying developmental neurovascular vulnerability, biomarker discovery, and preventive strategies.